Source: Eur Respir J 2015; 46: 175-185



Rating:

Share or cite this content

Citations should be made in the following way:
Vorselaars Adriane D.M., Crommelin Heleen A., Deneer Vera H.M., Meek Bob, Claessen Anke M.E., Keijsers Ruth G.M., van Moorsel Coline H.M., Grutters Jan C.. Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis. Eur Respir J 2015; 46: 175-185

Member's Comments

No comment yet.

Related content which might interest you: The Value of 18F-FDG PET/CT in evaluating disease severity in idiopathic pulmonary fibrosis Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Long-term treatment with infliximab in patients with sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 Value of 18F-FDG PET/CT for predicting postoperative acute exacerbation in idiopathic pulmonary fibrosis Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 CT and FDG PET/CT findings of pulmonary involvement in methotrexate-associated lymphoproliferative disease Source: International Congress 2018 – CC6 Interstitial lung diseases Year: 2018 Relapse after discontinuation of infliximab in sarcoidosis patients can be predicted by PET-scan and sIL-2R Source: Annual Congress 2013 –Sarcoidosis Year: 2013 Rituximab in the treatment of refractory pulmonary sarcoidosis Source: Eur Respir J 2014; 43: 1525-1528 Year: 2014 Adalimumab treatment in patients with sarcoidosis: An open clinical trial using FDG-PET Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside Year: 2010 The role of 18F-FDG PET/CT for the diagnosis and follow-up of relapsing polychondritis Source: Annual Congress 2013 –Morphologic imaging Year: 2013 Safety of corticosteroid therapy in patients with pulmonary sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 The utility of 18F-FDG PET/CT in chronic sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 The 18F PET/CT scan in patients with chronic sarcoidosis Source: International Congress 2016 – Sarcoidosis Year: 2016 Evaluation of pleural disease with FDG-PET imaging Source: Annual Congress 2003 - Early lung cancer diagnosis Year: 2003 Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis Source: Eur Respir J 2014; 44: 1296-1307 Year: 2014 Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab Source: International Congress 2016 – Sarcoidosis Year: 2016 Two-coloured magnetic-laser therapy in sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 81s Year: 2005 Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis Source: Eur Respir J 2014; 43: 602-609 Year: 2013 Title:68  Gallium DOTA-NOC PET/CT as a predictor of disease activity in sarcoidosis Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses Year: 2017 Analysis of the solitary pulmonary nodule after surgical resection in patients using 18F-FDG integrated PET-CT scan at preoperative work-up. Source: International Congress 2018 – Thoracic surgery, pleural effusions and other general thoracic surgery Year: 2018 The role of 18-FDG PET/CT in lung sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 FDG-PET/CT for monitoring the response to treatment in thoracic and pancreatic sarcoidosis Source: Annual Congress 2009 - Old and new: technique and pathology Year: 2009